Cerus Corporation Prices $70.0 Million Public Offering Of Common Stock

CONCORD, Calif.--(BUSINESS WIRE)--Cerus Corporation (NASDAQ:CERS) today announced the pricing of an underwritten public offering of 12,727,273 shares of its common stock, offered at a price to the public of $5.50 per share for expected gross proceeds of $70.0 million. The net proceeds to Cerus from this offering are expected to be approximately $65.5 million, after deducting the underwriting discount and estimated offering expenses payable by Cerus. The offering is expected to close on or about January 12, 2015, subject to customary closing conditions. In addition, Cerus has granted the underwriters a 30-day option to purchase up to an additional 1,909,090 shares of its common stock to cover overallotments, if any. Cerus anticipates using the net proceeds from the offering for continued development activities related to the INTERCEPT Blood System, to fund commercialization efforts for the INTERCEPT Blood System in the United States and elsewhere, and for other general corporate purposes, including regulatory activity, selling, general and administrative expenses and working capital.

Help employers find you! Check out all the jobs and post your resume.